medline.ch Respirationstrakt Neoplasie

	External Validation of The Proliferation Saturation Index Model in Predicting Tumour Volume Regression in Patients with Non-Small Cell Lung Cancer Undergoing Radiation Therapy. Int J Radiat Oncol Biol Phys Barrett S, Zahid M, McGarry CK, Enderling H, Walls GM, Marignol L. PMID: 41724248 [PubMed - as supplied by publisher]
	Comparison of long-term survival between nivolumab plus ipilimumab with chemotherapy and pembrolizumab with chemotherapy in advanced non-small cell lung cancer: A multicenter retrospective cohort study. Lung Cancer Kinehara Y, Matsumoto K, Shiroyama T, Komuta K, Tamiya M, Nishino K, Tamiya A, Kuge T, Uchida J, Suzuki H, Yamamoto S, Tobita S, Niki T, Tetsumoto S, Morimura O, Osa A, Minami T, Nagatomo I, Takeda Y, Kijima T, Kumanogoh A. PMID: 41723915 [PubMed - as supplied by publisher]
	Upfront treatment with osimertinib in lung cancer patients with and without active brain metastases, and the role of ctDNA as a biomarker; a phase II clinical trial (the FIOL study). Lung Cancer Stensland EM, Stensgaard S, Eide IJZ, Nilssen Y, Horndalsveen H, Cicenas S, Grønberg BH, Ekman S, Hansen KH, Sorensen BS, Brustugun OT. PMID: 41723914 [PubMed - as supplied by publisher]
	Economic burden of advanced non-small cell lung cancer (NSCLC): a systematic literature review. J Med Econ Jovanoski N, Kaur G, Shukla H, Chana N, Kharawala S. PMID: 41723781 [PubMed - indexed for MEDLINE]
	National Screening, National Responsibility: Turning Promise Into Progress for Lung Cancer Care. Med J Aust Brims FJ. PMID: 41723710 [PubMed - indexed for MEDLINE]
	From radiologic morphology to component proportion: a multicenter study on the progression and prognosis of lung adenocarcinoma with cystic airspaces. Cancer Imaging Fu C, Bian C, Du H, Wang Y, Zhang J, Li X, Cao L, Zhu J, Wang J. PMID: 41723563 [PubMed - as supplied by publisher]
	The Histone-Modified Landscape: Core Mechanisms of Osimertinib Resistance in EGFR-Mutant Lung Cancer. Cancer Lett Yang J, Zhang M, Gao C, Yao X, Sun C, Zhuang J. PMID: 41722838 [PubMed - as supplied by publisher]
	QVT score, a radiomic biomarker of vascular complexity, enables prognostication and monitoring of NSCLC immunotherapy. J Immunother Cancer Chae YK, Velcheti V, Zhang K, Hiremath A, Chung LI, Haji-Maghsoudi O, Chitalia R, Lee J, Li H, Lee S, Mutha P, Nagabhushan R, Levy D, Cantor D, Kim Y, Cheung T, Kim H, Gupta A, Arul T, Madabhushi A, Braman N. PMID: 41720608 [PubMed - indexed for MEDLINE]
	Correction to "Prevalence and Correlates of Distress Detected by the Distress Thermometer and Problem List in Lung Cancer Patients: A Cross-Sectional Study". Thorac Cancer PMID: 41720477 [PubMed - in process]
	Smoking-dependent circulating non-coding biomarkers in lung cancer. Clin Chim Acta Farasani A. PMID: 41720438 [PubMed - as supplied by publisher]
	Efficacy of immune checkpoint inhibitors in the first line therapy of non-squamous non-small cell lung cancer: a systematic review and network meta-analysis. Crit Rev Oncol Hematol Fedyanin M, Zhukov N, Moiseenko F, Mironenko O, Sapozhnikov K, Sableva N, Lazarev A, Tolkacheva D. PMID: 41720325 [PubMed - as supplied by publisher]
	Treatment of Lung Neuroendocrine Tumors with (177)Lu-DOTATATE: Experience from a Tertiary Oncology Center. Rev Esp Med Nucl Imagen Mol (Engl Ed) Dos Santos SG, Fernandes AM, Ferreira G, Paula Santos A, Sampaio IL. PMID: 41720218 [PubMed - as supplied by publisher]
	Prediction of Symptomatic Radiation Pneumonitis in Lung Cancer Patients: A Radiomics and Dosiomics Machine Learning Approach Using the Prospective Multicenter RTOG 0617 and REQUITE trials. Int J Radiat Oncol Biol Phys Reuter LM, Kraus KM, Fischer SM, Pletzer D, Bernhardt D, Combs SE, Schnabel JA, Peeken JC. PMID: 41720170 [PubMed - as supplied by publisher]
	Predicting neoadjuvant immunotherapy efficacy with machine learning models in non-small cell lung cancer: A systematic review and meta analysis. Int J Med Inform Liu W, Feng Z, Zhang M, Mao R, Li J. PMID: 41719848 [PubMed - as supplied by publisher]
	Fusing data from CT deep learning, CT radiomics and peripheral blood immune profiles to diagnose lung cancer in a cohort of patients experiencing symptoms. EBioMedicine Mustapha R, Ganeshan B, Ellis S, Dolcetti L, Tharmakulasingam M, DeSouza K, Jiang X, Savage C, Lim S, Chan E, Thornton A, Hoy L, Endozo R, Shortman R, Walls D, Chen SH, Rowley M, Coolen ACC, Groves AM, Schnabel JA, Win T, Barber PR, Ng T. PMID: 41719793 [PubMed - as supplied by publisher]
	Molecular factors associated with lung cancer in people living with HIV. Braz J Infect Dis Bautista-Rojas ID, Figueroa-Navarrete J, Reyes-Hernandez DL, Rivera-Toledo E. PMID: 41719623 [PubMed - as supplied by publisher]
	Topologically distinct 2D and 3D intratumoral heterogeneity scores for preoperatively predicting invasiveness in stage I lung adenocarcinoma: A multicenter study. PLOS Digit Health Zuo Z, Fan X, Zeng Y, Qi W, Liu W, Li W, Liang Q. PMID: 41719325 [PubMed]
	Combining evidence and practice: evaluating proton re-irradiation in recurrent lung cancer. Int J Radiat Biol Liu Y, He J, Li B, Wang Y, Yang H, Wang L. PMID: 41718539 [PubMed - as supplied by publisher]
	A Self-Supervised Foundation Model Based on Three-Dimensional Chest CT Scans for Lung Cancer Diagnosis and Prognosis Prediction. Radiol Imaging Cancer Li J, Xing Y, Gao X, Ye Z, Wang M, Song F. PMID: 41718531 [PubMed - indexed for MEDLINE]
	Letter: Development and Validation of a Modified Khorana Score for Predicting Venous Thromboembolism in Newly Diagnosed Stage IV Lung Cancer. Angiology Long J, Shen Q. PMID: 41718527 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 157439

Seite 1 von 7872



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung